After-Hours Movers: GameStop, Dave & Buster's, Viridian Therapeutics

GameStop (NYSE: GME)

Shares of GameStop rose 5.8% in after-hours trading on Tuesday after the video game retailer reported better-than-expected quarterly results.

GameStop reported a loss per share of $2.27 in the first quarter, narrower than the $3.43 loss per share analysts had forecast.

Revenue came in at $1.38 billion, above the $1.34 billion analysts had expected and a 16% increase over the same period last year.

Dave & Buster's (NASDAQ: PLAY)

Shares of Dave & Buster's rose 4.3% in after-hours trading after the family entertainment company reported better-than-expected quarterly results.

Dave & Buster's reported earnings per share of $2.28 in the fourth quarter, higher than the $2.19 per share analysts had forecast.

Revenue came in at $492.4 million, above the $487.2 million analysts had expected and a 12% increase over the same period last year.

Viridian Therapeutics (NASDAQ: VRDN)

Shares of Viridian Therapeutics rose 2.4% in after-hours trading after the clinical-stage biopharmaceutical company reported positive data from a Phase 2 clinical trial of its lead drug candidate.

The data showed that the drug, VRDN-001, was safe and well-tolerated and that it led to a significant reduction in the number of pain crises in patients with sickle cell disease.

Viridian Therapeutics said that it plans to initiate a Phase 3 clinical trial of VRDN-001 later this year.